Literature DB >> 19672572

[Comorbidity of substance use disorders and attention-deficit hyperactivity disorders: pathogenesis and therapy].

A J Fallgatter1, C P Jacob.   

Abstract

Substance use disorders (e.g. substance addiction, substance abuse) and adult attention-deficit hyperactivity disorders (adult ADHD) are frequent psychiatric disorders with a high individual and social relevance. Complex interactions of common and divergent susceptibility genes and environmental factors are important for both disorders which have a relatively high heritability. Substance use disorders and adult ADHD are both associated with an increased risk for additional axis I disorders. The results of studies with respect to the comorbidity of adult ADHD and substance use disorders are inconsistent. Different hypotheses with respect to comorbidity are under discussion. A standardised diagnostic procedure has to be followed. The consequence of misdiagnosing adult ADHD with comorbid substance use disorder is that relevant specific therapeutic procedures will not be followed or stimulants will be prescribed too easily for individuals with substance use disorders. Multimodal integrated therapeutic concepts for the comorbidity of substance use disorders and adult ADHD have yet to be developed.

Entities:  

Mesh:

Year:  2009        PMID: 19672572     DOI: 10.1007/s00115-009-2742-0

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  28 in total

1.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

2.  Young adult follow-up of hyperactive children: self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems and teen CD.

Authors:  Mariellen Fischer; Russell A Barkley; Lori Smallish; Kenneth Fletcher
Journal:  J Abnorm Child Psychol       Date:  2002-10

Review 3.  Comorbidity in adults with attention-deficit/hyperactivity disorder.

Authors:  D J Marks; J H Newcorn; J M Halperin
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

Review 4.  Molecular genetics of attention-deficit/hyperactivity disorder.

Authors:  Stephen V Faraone; Roy H Perlis; Alysa E Doyle; Jordan W Smoller; Jennifer J Goralnick; Meredith A Holmgren; Pamela Sklar
Journal:  Biol Psychiatry       Date:  2005-01-21       Impact factor: 13.382

5.  Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center.

Authors:  Christian P Jacob; Jasmin Romanos; Astrid Dempfle; Monika Heine; Christine Windemuth-Kieselbach; Anja Kruse; Andreas Reif; Susanne Walitza; Marcel Romanos; Alexander Strobel; Burkhard Brocke; Helmut Schäfer; Armin Schmidtke; Jobst Böning; Klaus-Peter Lesch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-04-01       Impact factor: 5.270

6.  Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study.

Authors:  P Rasmussen; C Gillberg
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-11       Impact factor: 8.829

Review 7.  Genetics of dopamine receptors and drug addiction: a comprehensive review.

Authors:  Bernard Le Foll; Alexandra Gallo; Yann Le Strat; Lin Lu; Philip Gorwood
Journal:  Behav Pharmacol       Date:  2009-02       Impact factor: 2.293

8.  Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

Authors:  David Michelson; Lenard Adler; Thomas Spencer; Frederick W Reimherr; Scott A West; Albert J Allen; Douglas Kelsey; Joachim Wernicke; Anthony Dietrich; Denái Milton
Journal:  Biol Psychiatry       Date:  2003-01-15       Impact factor: 13.382

Review 9.  [Multimodal treatment of adult attention-deficit hyperactivity disorder].

Authors:  C P Jacob; A Philipsen; D Ebert; J Deckert
Journal:  Nervenarzt       Date:  2008-07       Impact factor: 1.214

10.  Association of ADH1B and ALDH2 gene polymorphisms with alcohol dependence: a pilot study from India.

Authors:  Meera Vaswani; Pushplata Prasad; Suman Kapur
Journal:  Hum Genomics       Date:  2009-04       Impact factor: 4.639

View more
  1 in total

Review 1.  [Methylphenidate. Therapy option for adults with ADHD and comorbid substance use disorder?].

Authors:  G Paslakis; F Kiefer; A Diehl; B Alm; E Sobanski
Journal:  Nervenarzt       Date:  2010-03       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.